-
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
van der Schans, J. J., Wang, Z., van Arkel, J., van Schaik, T., Katsarou, A., Ruiter, R., Baardemans, T., Yuan, H., de Bruijn, J., Zweegman, S., van de Donk, N. W. C. J., Groen, R. W. J., Themeli, M. & Mutis, T., 15 Oct 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 20, p. 4219-4229 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Bone marrow mesenchymal stromal cells can render multiple myeloma cells resistant to cytotoxic machinery of CAR T cells through inhibition of apoptosis
Holthof, L. C., van der Schans, J. J., Katsarou, A., Poels, R., Gelderloos, A. T., Drent, E., van Hal-van Veen, S. E., Li, F., Zweegman, S., van de Donk, N. W. C. J., Themeli, M., Groen, R. W. J. & Mutis, T., 1 Jul 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 27, 13, p. 3793-3803 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
CD38-specific chimeric antigen receptor expressing natural killer KHYG-1 cells: A proof of concept for an "Off the Shelf" therapy for multiple myeloma
Stikvoort, A., van der Schans, J., Sarkar, S., Poels, R., Ruiter, R., Naik, J., Yuan, H., de Bruijn, J. D., van de Donk, N. W. C. J., Zweegman, S., Themeli, M., Groen, R., O'Dwyer, M. & Mutis, T., Jul 2021, In: HemaSphere. e596.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
